loading
Schlusskurs vom Vortag:
$6.46
Offen:
$6.38
24-Stunden-Volumen:
738.77K
Relative Volume:
1.37
Marktkapitalisierung:
$207.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.25M
KGV:
-5.371
EPS:
-1.186
Netto-Cashflow:
$-22.80M
1W Leistung:
-10.03%
1M Leistung:
-16.29%
6M Leistung:
+56.13%
1J Leistung:
+21.33%
1-Tages-Spanne:
Value
$6.19
$6.55
1-Wochen-Bereich:
Value
$6.08
$7.285
52-Wochen-Spanne:
Value
$1.73
$11.41

Sagimet Biosciences Inc Stock (SGMT) Company Profile

Name
Firmenname
Sagimet Biosciences Inc
Name
Telefon
(650) 561-8600
Name
Adresse
155 BOVET RD., SUITE 303, SAN MATEO
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
SGMT's Discussions on Twitter

Vergleichen Sie SGMT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SGMT
Sagimet Biosciences Inc
6.37 210.09M 0 -29.25M -22.80M -1.186
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.26 117.50B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
722.83 76.06B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.56 62.53B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
916.31 56.75B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
205.04 44.10B 447.02M -1.18B -906.14M -6.1812

Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-11 Eingeleitet Wedbush Outperform
2025-08-07 Fortgesetzt H.C. Wainwright Buy
2025-07-24 Eingeleitet Canaccord Genuity Buy
2024-12-06 Eingeleitet Oppenheimer Outperform
2024-11-12 Eingeleitet UBS Buy
2024-06-28 Herabstufung Goldman Buy → Neutral
2024-05-02 Eingeleitet H.C. Wainwright Buy
2024-03-25 Eingeleitet Leerink Partners Outperform
2023-08-08 Eingeleitet Goldman Buy
2023-08-08 Eingeleitet JMP Securities Mkt Outperform
2023-08-08 Eingeleitet Piper Sandler Overweight
2023-08-08 Eingeleitet TD Cowen Outperform
Alle ansehen

Sagimet Biosciences Inc Aktie (SGMT) Neueste Nachrichten

pulisher
02:21 AM

Is Sagimet Biosciences Inc. (0O2) stock worth holding before Fed meetingQuarterly Risk Review & Daily Risk Controlled Trade Plans - Newser

02:21 AM
pulisher
Dec 04, 2025

Is Sagimet Biosciences Inc. (0O2) stock prepared for digital transitionWeekly Trade Analysis & Low Risk High Reward Trade Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How Sagimet Biosciences Inc. (0O2) stock trades after earningsTrade Ideas & Verified Technical Trade Signals - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How cyclical is Sagimet Biosciences Inc. (0O2) stock compared to rivalsJuly 2025 WrapUp & Accurate Trade Setup Notifications - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Is Sagimet Biosciences Inc. (0O2) stock a buy during volatile markets2025 Biggest Moves & Precise Entry and Exit Recommendations - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Why Sagimet Biosciences Inc. (0O2) stock stays undervaluedCEO Change & Entry Point Strategy Guides - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

How resilient is Sagimet Biosciences Inc. stock in market downturnsEarnings Miss & High Return Trade Opportunity Guides - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Will Sagimet Biosciences Inc. stock benefit from commodity prices2025 Market Outlook & Real-Time Market Trend Scan - Newser

Dec 02, 2025
pulisher
Nov 22, 2025

Sagimet Biosciences executive chairman sells $290k in shares By Investing.com - Investing.com Australia

Nov 22, 2025
pulisher
Nov 21, 2025

Insider Sell: George Kemble Sells Shares of Sagimet Biosciences Inc (SGMT) - GuruFocus

Nov 21, 2025
pulisher
Nov 21, 2025

Sagimet Biosciences executive chairman sells $290k in shares - Investing.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Sagimet Biosciences Inc. (0O2) stock sustain bullish trend into 2025Weekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference - The Manila Times

Nov 20, 2025
pulisher
Nov 20, 2025

Sagimet Biosciences Inc. to Participate in 8th Annual Evercore ISI Healthcare Conference on December 2, 2025 - Quiver Quantitative

Nov 20, 2025
pulisher
Nov 19, 2025

Why Sagimet Biosciences Inc. (0O2) stock attracts wealthy investorsMarket Risk Summary & Growth Focused Investment Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Sagimet Biosciences Inc. (0O2) stock attract analyst upgradesPortfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What catalysts could drive Sagimet Biosciences Inc. stock higherPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Detecting support and resistance levels for Sagimet Biosciences Inc.July 2025 Outlook & Safe Capital Preservation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Sagimet Biosciences Inc (0O2.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nov 19, 2025
pulisher
Nov 19, 2025

How sustainable is Sagimet Biosciences Inc. stock dividend payoutJuly 2025 Short Interest & Safe Capital Allocation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Identifying reversal signals in Sagimet Biosciences Inc.Rate Cut & Fast Exit and Entry Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Reversal indicators forming on Sagimet Biosciences Inc. stockWeekly Stock Summary & Consistent Income Trade Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 02:00:25 - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will Sagimet Biosciences Inc. rebound enough to break evenGap Down & Comprehensive Market Scan Reports - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Sagimet Biosciences Advances Denifanstat: Q3 Earnings And Upcoming Catalysts - Seeking Alpha

Nov 18, 2025
pulisher
Nov 17, 2025

Is Sagimet Biosciences Inc. stock resilient to inflation2025 Growth vs Value & High Accuracy Buy Signal Tips - newser.com

Nov 17, 2025

Finanzdaten der Sagimet Biosciences Inc-Aktie (SGMT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$39.16
price down icon 1.10%
$100.48
price down icon 1.00%
$32.03
price up icon 1.10%
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
$205.04
price down icon 0.84%
Kapitalisierung:     |  Volumen (24h):